Genomics

Dataset Information

0

Phase II Study of Immune Checkpoint Blockade with Pembrolizumab after High Dose Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia


ABSTRACT: Phase II Study of Immune Checkpoint Blockade with Pembrolizumab after High Dose Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia

PROVIDER: PRJNA760534 | ENA |

REPOSITORIES: ENA

Similar Datasets

2021-09-09 | GSE183415 | GEO
| PRJNA800756 | ENA
2022-01-26 | GSE195471 | GEO
| PRJNA842141 | ENA
| PRJNA842142 | ENA
| S-EPMC8580622 | biostudies-literature
2023-12-31 | GSE225239 | GEO
| PRJNA661354 | ENA
| PRJNA661355 | ENA
2021-05-19 | GSE171003 | GEO